Hata F, Kondo E, Kondo S, Kagawa K, Ishida H
Jpn J Pharmacol. 1982 Feb;32(1):181-7. doi: 10.1254/jjp.32.181.
Radiolabeled E-643, a newly developed antihypertensive compound, bound specifically to a preparation obtained from rat brain with a maximum of 85 f moles of binding sites per mg protein and a dissociation constant of 0.59 nM. Prazosin markedly inhibited the binding. While yohimbine and clonidine were only weak inhibitors. Other characteristics of the binding of [3H]E-643 to the brain and its specific binding to preparations of peripheral rat organs were also studied. The present findings suggest that [3H]E-643 is useful for labeling alpha 1-adrenoceptors.
放射性标记的E - 643是一种新开发的抗高血压化合物,它能特异性结合从大鼠脑中提取的制剂,每毫克蛋白质的最大结合位点为85飞摩尔,解离常数为0.59纳摩尔。哌唑嗪显著抑制这种结合。而育亨宾和可乐定只是弱抑制剂。还研究了[3H]E - 643与脑结合的其他特性及其与大鼠外周器官制剂的特异性结合。目前的研究结果表明,[3H]E - 643可用于标记α1 -肾上腺素能受体。